Cargando…
Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, OCTAVE open
[Image: see text]
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311428/ https://www.ncbi.nlm.nih.gov/pubmed/35246988 http://dx.doi.org/10.1111/apt.16848 |
| _version_ | 1784753594471284736 |
|---|---|
| author | Panaccione, Remo Abreu, Maria T. Lazariciu, Irina Mundayat, Rajiv Lawendy, Nervin Salese, Leonardo Woolcott, John C. Sands, Bruce E. Chaparro, María |
| author_facet | Panaccione, Remo Abreu, Maria T. Lazariciu, Irina Mundayat, Rajiv Lawendy, Nervin Salese, Leonardo Woolcott, John C. Sands, Bruce E. Chaparro, María |
| author_sort | Panaccione, Remo |
| collection | PubMed |
| description | [Image: see text] |
| format | Online Article Text |
| id | pubmed-9311428 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93114282022-07-29 Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, OCTAVE open Panaccione, Remo Abreu, Maria T. Lazariciu, Irina Mundayat, Rajiv Lawendy, Nervin Salese, Leonardo Woolcott, John C. Sands, Bruce E. Chaparro, María Aliment Pharmacol Ther Tofacitinib in Ulcerative Colitis [Image: see text] John Wiley and Sons Inc. 2022-03-05 2022-06 /pmc/articles/PMC9311428/ /pubmed/35246988 http://dx.doi.org/10.1111/apt.16848 Text en © 2022 Pfizer Inc. Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Tofacitinib in Ulcerative Colitis Panaccione, Remo Abreu, Maria T. Lazariciu, Irina Mundayat, Rajiv Lawendy, Nervin Salese, Leonardo Woolcott, John C. Sands, Bruce E. Chaparro, María Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, OCTAVE open |
| title | Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, OCTAVE open |
| title_full | Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, OCTAVE open |
| title_fullStr | Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, OCTAVE open |
| title_full_unstemmed | Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, OCTAVE open |
| title_short | Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, OCTAVE open |
| title_sort | persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, octave open |
| topic | Tofacitinib in Ulcerative Colitis |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311428/ https://www.ncbi.nlm.nih.gov/pubmed/35246988 http://dx.doi.org/10.1111/apt.16848 |
| work_keys_str_mv | AT panaccioneremo persistenceoftreatmentinpatientswithulcerativecolitiswhorespondedtotofacitinibtherapydatafromtheopenlabellongtermextensionstudyoctaveopen AT abreumariat persistenceoftreatmentinpatientswithulcerativecolitiswhorespondedtotofacitinibtherapydatafromtheopenlabellongtermextensionstudyoctaveopen AT lazariciuirina persistenceoftreatmentinpatientswithulcerativecolitiswhorespondedtotofacitinibtherapydatafromtheopenlabellongtermextensionstudyoctaveopen AT mundayatrajiv persistenceoftreatmentinpatientswithulcerativecolitiswhorespondedtotofacitinibtherapydatafromtheopenlabellongtermextensionstudyoctaveopen AT lawendynervin persistenceoftreatmentinpatientswithulcerativecolitiswhorespondedtotofacitinibtherapydatafromtheopenlabellongtermextensionstudyoctaveopen AT saleseleonardo persistenceoftreatmentinpatientswithulcerativecolitiswhorespondedtotofacitinibtherapydatafromtheopenlabellongtermextensionstudyoctaveopen AT woolcottjohnc persistenceoftreatmentinpatientswithulcerativecolitiswhorespondedtotofacitinibtherapydatafromtheopenlabellongtermextensionstudyoctaveopen AT sandsbrucee persistenceoftreatmentinpatientswithulcerativecolitiswhorespondedtotofacitinibtherapydatafromtheopenlabellongtermextensionstudyoctaveopen AT chaparromaria persistenceoftreatmentinpatientswithulcerativecolitiswhorespondedtotofacitinibtherapydatafromtheopenlabellongtermextensionstudyoctaveopen |